SCHEMBL199711

SCHEMBL199711

[CH2]CCCCCCCCCCCCCCCCCCCCCCC

nearest known ligand 0.61

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.61
THRB P10828 1/20 0.61
DNM1 Q05193 6/20 0.44
ALDH1A1 P00352 3/20 0.44
LMNA P02545 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
HSD17B10 Q99714 1/20 0.44
SLC22A1 O15245 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1878825 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL8420 1.00
SCHEMBL629331 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL158879 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL8462 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL1874289 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL144689 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL2187 1.00
SCHEMBL3056 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL284790 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 320 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030852-B2 Method for producing fatty alcohol esters of hydroxycarboxylic acids IOI OLEO GMBH (DE) 2024-07-09 US claimed
CN-113993833-B Method for producing acyl-terminated 3-hydroxycarboxylic acid and salts and esters thereof 凯托利皮克斯治疗有限责任公司 2024-05-10 CN claimed
US-20230226087-A1 PHOSPHOLIPIDS AND PHOSPHOLIPID METABOLITES FOR TREATING VIRAL AND BACTERIAL PNEUMONIA AND SEPSIS ANDREAS HETTICH GMBH & CO. KG (DE) 2023-07-20 US claimed
US-20230159430-A1 METHOD FOR PRODUCING FATTY ALCOHOL ESTERS OF HYDROXYCARBOXYLIC ACIDS IOI OLEO GMBH (DE) 2023-05-25 US claimed
EP-4135714-A1 PHOSPHOLIPIDS AND PHOSPHOLIPID METABOLITES FOR TREATING VIRAL AND BACTERIAL PNEUMONIA AND SEPSIS Andreas Hettich GmbH & Co. KG (DE) 2023-02-22 EP claimed
EP-3956282-A1 PROCESS FOR PREPARING ACYL-CAPPED 3-HYDROXYCARBOXYLIC ACIDS AND THEIR SALTS AND ESTERS IOI Oleo GmbH (DE) 2022-02-23 EP claimed
CN-113993833-A Process for producing acyl-terminated 3-hydroxycarboxylic acids and salts and esters thereof IOI油脂化学品有限责任公司 2022-01-28 CN claimed
CN-113508105-A Process for producing fatty alcohol esters of hydroxycarboxylic acids IOI油脂化学品有限责任公司 2021-10-15 CN claimed
EP-3880642-A1 METHOD FOR PRODUCING FATTY ALCOHOL ESTERS OF HYDROXY CARBOXYLIC ACIDS IOI Oleo GmbH (DE) 2021-09-22 EP claimed
US-20210188759-A1 ALKOXYLATED HYDROXYBENZOIC ACID ESTERS OR AMIDES CLARIANT INTERNATIONAL LTD. (CH) 2021-06-24 US claimed
EP-1753708-B1 NOVEL SIRTUIN ACTIVATING COMPOUNDS AND METHODS FOR MAKING THE SAME UNIV BRIGHAM YOUNG (US) 2018-02-21 EP claimed
WO-2017140510-A1 ALKOXYLATED HYDROXYBENZOIC ACID ESTERS OR AMIDES CLARIANT INTERNATIONAL LTD (CH) 2017-08-24 WO claimed
EP-3208260-A1 ALKOXYLATED HYDROXYBENZOIC ACID ESTERS OR AMIDES Clariant International Ltd (CH) 2017-08-23 EP claimed
US-20170158796-A1 POLYMERIC COMPOSITIONS AS POUR POINT DEPRESSANTS FOR CRUDE OILS BASF SE (DE) 2017-06-08 US claimed
US-8623888-B2 3-oxy-hydromorphone derivatives MALLINCKRODT LLC (US) 2014-01-07 US claimed
US-20110015398-A1 3-Oxy-Hydromorphone Derivatives MALLINCKRODT INC. (US) 2011-01-20 US claimed
WO-2011008636-A1 3-OXY-HYDROMORPHONE DERIVATIVES MALLINCKRODT INC. (US) 2011-01-20 WO claimed
US-20100305198-A1 CATIONIC LIPIDS THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURG (GB) 2010-12-02 US claimed
EP-2212279-A1 CATIONIC LIPIDS The University Court Of The University of Edinburgh (GB) 2010-08-04 EP claimed
WO-2009050483-A1 CATIONIC LIPIDS THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) 2009-04-23 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12030852-B2 Method for producing fatty alcohol esters of hydroxycarboxylic acids FASN, HSD17B12, SCD TSHR 2979/4885THRB 1101/4885DNM1 3492/4885
US-20210188759-A1 ALKOXYLATED HYDROXYBENZOIC ACID ESTERS OR AMIDES HCAR3, MSR1, ELOVL3 TSHR 562/4885THRB 492/4885DNM1 2589/4885
US-20110015398-A1 3-Oxy-Hydromorphone Derivatives OPRD1, OPRK1, OPRM1 TSHR 1736/4885THRB 774/4885DNM1 3520/4885
US-20230226087-A1 PHOSPHOLIPIDS AND PHOSPHOLIPID METABOLITES FOR TREATING VIRAL AND BACTERIAL PNEUMONIA AND SEPSIS PHOSPHO1, SGMS2, SGMS1 TSHR 2649/4885THRB 2513/4885DNM1 2082/4885
US-20100305198-A1 CATIONIC LIPIDS CETP, LIPA, ABHD16A TSHR 1862/4885THRB 3055/4885DNM1 277/4885
US-20230159430-A1 METHOD FOR PRODUCING FATTY ALCOHOL ESTERS OF HYDROXYCARBOXYLIC ACIDS FASN, HSD17B12, SCD TSHR 2979/4885THRB 1101/4885DNM1 3492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.